Antibodies In-Depth Focus 2017

Posted: 15 March 2017 | | No comments yet

Lone Friis and David Matthews discuss developability assessment of therapeutic antibodies, and Negin Mokhtari and colleagues explain nanoparticle-mediated enzyme delivery for application in cancer therapy…

digital issue #1 2017 in-depth focus antibodies

Included in this Antibodies In-Depth Focus:

  • Developability assessment of therapeutic antibodies
    Lone Friis and David Matthews – MRC Technology Centre for Therapeutics Discovery
  • Antibody-based immunooncology: hopes and perils
    Ismael Samudio, The Centre for Drug Research and Development (CDRD) and Gregorio Aversa, Immcure Theraputics

This Antibodies In-Depth Focus is restricted - login or subscribe free to access

DTR Issue 3 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here